InsiderTrades.com logo
Next opportunity for crypto millions
From Crypto 101 Media   |   Ad
The floodgates have opened. Bitcoin and Ethereum ETFs are seeing record-breaking inflows, the biggest since they first opened to investors. Wall Street is finally embracing crypto. But most investors are missing the real goldmine…
Go here to discover the crypto that's about to leave Wall Street in the dust.

LENZ Insider Trading

Insider Ownership Percentage: 38.40%
Insider Buying (Last 12 Months): $15,501,073.95
Insider Selling (Last 12 Months): $0.00

LENZ Therapeutics Insider Trading History Chart

This chart shows the insider buying and selling history at LENZ Therapeutics by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

LENZ Therapeutics Share Price & Price History

Current Price: $25.78
Price Change: ▲ Price Increase of +3.3 (14.68%)
As of 10/4/2024 01:00 AM ET

This chart shows the closing price history over time for LENZ up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365
How a $200,000 Mistake Unlocked a $118 Billion Gold Treasure
From Monument Traders Alliance   |   Ad
The window of opportunity on this gold stock is closing fast. Once word gets out, it may be too late.
Click here now to learn how you can position yourself for potentially massive gains.

LENZ Therapeutics Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
5/13/2024James W MccollumDirectorBuy31,332$15.99$500,998.68525,565View SEC Filing Icon  
3/21/2024Ra Capital Management, L.P.DirectorBuy998,009$15.03$15,000,075.273,319,339View SEC Filing Icon  
See Full Table
320 hedge funds just sold this stock
From Chaikin Analytics   |   Ad
320 hedge funds just sold this stock A strange force has seized control of Wall Street. Hedge funds are already moving their money… and preparing for even stranger days ahead. Over 320 hedge funds have quietly sold THIS famous stock – to prepare for a dramatic market shift
Get the strange truth from a 50-year Wall Street insider… including the name and ticker of the stock

SEC Filings (Institutional Ownership Changes) for LENZ Therapeutics (NASDAQ:LENZ)

54.32% of LENZ Therapeutics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at LENZ by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

LENZ Therapeutics Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
10/3/2024SG Americas Securities LLC4,523$0.11M0.0%N/A0.124%Search for SEC Filing on Google Icon
8/15/2024Deerfield Management Company L.P. Series C17,353$0.30M0.0%N/A0.476%Search for SEC Filing on Google Icon
8/14/2024Squarepoint Ops LLC10,477$0.18M0.0%N/A0.287%Search for SEC Filing on Google Icon
8/14/2024Marshall Wace LLP22,554$0.39M0.0%N/A0.618%Search for SEC Filing on Google Icon
8/9/2024Renaissance Technologies LLC60,166$1.04M0.0%+28.4%1.649%Search for SEC Filing on Google Icon
8/9/2024Dimensional Fund Advisors LP37,190$0.64M0.0%+58.0%1.019%Search for SEC Filing on Google Icon
8/5/2024BBR Partners LLC20,000$0.35M0.0%N/A0.548%Search for SEC Filing on Google Icon
8/1/2024Rhumbline Advisers16,812$0.29M0.0%+265.6%0.461%Search for SEC Filing on Google Icon
7/26/2024Bank of New York Mellon Corp39,737$0.69M0.0%+255.4%1.089%Search for SEC Filing on Google Icon
7/16/2024Wealth Enhancement Advisory Services LLC83,103$1.44M0.0%N/A2.277%Search for SEC Filing on Google Icon
5/17/2024RA Capital Management L.P.4,178,823$93.31M1.2%N/A114.488%Search for SEC Filing on Google Icon
5/17/2024Ikarian Capital LLC85,000$1.90M0.2%N/A2.329%Search for SEC Filing on Google Icon
5/16/2024Jacobs Levy Equity Management Inc.37,176$0.83M0.0%N/A1.019%Search for SEC Filing on Google Icon
5/14/2024American International Group Inc.1,973$44K0.0%N/A0.054%Search for SEC Filing on Google Icon
5/10/2024Vanguard Group Inc.206,952$4.62M0.0%N/A5.670%Search for SEC Filing on Google Icon
5/7/2024Marquette Asset Management LLC5,865$0.13M0.0%N/A0.161%Search for SEC Filing on Google Icon
5/2/2024Jennison Associates LLC134,740$3.01M0.0%N/A3.692%Search for SEC Filing on Google Icon
5/1/2024BNP Paribas Financial Markets16,221$0.36M0.0%N/A0.444%Search for SEC Filing on Google Icon
4/25/2024BML Capital Management LLC63,916$1.43M0.9%N/A1.751%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
LENZ Therapeutics logo
LENZ Therapeutics, Inc., a biopharmaceutical company, focuses on developing and commercializing therapies to improve vision in the United States. Its product candidates include LNZ100 and LNZ101 which are in Phase III clinical trials for the treatment of presbyopia. The company is headquartered in Del Mar, California.
Read More on LENZ Therapeutics

Today's Range

Now: $25.78
Low: $22.44
High: $25.85

50 Day Range

MA: $22.88
Low: $20.65
High: $25.10

52 Week Range

Now: $25.78
Low: $14.07
High: $29.82

Volume

305,115 shs

Average Volume

133,127 shs

Market Capitalization

$94.07 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.39

Who are the company insiders with the largest holdings of LENZ Therapeutics?

LENZ Therapeutics' top insider investors include:
  1. Ra Capital Management, LP (Director)
  2. James W Mccollum (Director)
Learn More about top insider investors at LENZ Therapeutics.

Who are the major institutional investors of LENZ Therapeutics?

LENZ Therapeutics' top institutional investors include:
  1. SG Americas Securities LLC — 0.12%
Learn More about top institutional investors of LENZ Therapeutics stock.

Which institutional investors are buying LENZ Therapeutics stock?

In the last quarter, LENZ stock was acquired by institutional investors including:
  1. SG Americas Securities LLC
In the previous year, these company insiders have bought LENZ Therapeutics stock:
  1. Ra Capital Management, LP (Director)
  2. James W Mccollum (Director)
Learn More investors buying LENZ Therapeutics stock.
How much money are you leaving on the table from the stocks you already own?
From Unstoppable Prosperity   |   Ad
Charles Payne here, and I want to let you in on a time-tested trading method that can be used to generate cash flow. Simply put, this time-tested 3-step strategy allows anyone to create cash flow from the stocks you already own without selling a single share in your portfolio. I call it "The Cash Flow Trade", and my team is going to teach you how and when to execute it in this free live event.
CLICK HERE TO RSVP